Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T11:07:28.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T13:06:38.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The error page footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T12:38:58.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message and a Home link in place of study information.
    Difference
    0.5%
    Check dated 2026-10-03T13:50:44.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, with a basic HTML header/footer and a 403 title, replacing the previous study content for the NCT03783078 study.
    Difference
    19%
    Check dated 2026-09-19T21:53:10.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added 2018 U.S. NIH Grant/Contract funding attribution. Updated the page revision to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T20:12:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.